Your browser doesn't support javascript.
loading
Exosomal HMGA2 protein from EBV-positive NPC cells destroys vascular endothelial barriers and induces endothelial-to-mesenchymal transition to promote metastasis.
Li, Deng-Ke; Chen, Xing-Rui; Wang, Li-Na; Wang, Jia-Hong; Li, Ji-Ke; Zhou, Zi-Ying; Li, Xin; Cai, Lin-Bo; Zhong, Shui-Sheng; Zhang, Jing-Jing; Zeng, Yu-Mei; Zhang, Qian-Bing; Fu, Xiao-Yan; Lyu, Xiao-Ming; Li, Min-Ying; Huang, Zhong-Xi; Yao, Kai-Tai.
Afiliación
  • Li DK; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Chen XR; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Wang LN; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Wang JH; Guangzhou First People's Hospital, School of Medicine, Southern China University of Technology, Guangzhou, 510180, China.
  • Li JK; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Zhou ZY; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Li X; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Cai LB; Shenzhen Key Laboratory of Viral Oncology, the Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, 518110, China.
  • Zhong SS; Guangdong Sanjiu Brain Hospital, Guangzhou, 510510, China.
  • Zhang JJ; Guangdong Sanjiu Brain Hospital, Guangzhou, 510510, China.
  • Zeng YM; Department of Radiotherapy, Tumor Hospital of Zhongshan People's Hospital, Zhongshan, 528403, China.
  • Zhang QB; Department of Pathology, Tumor Hospital of Zhongshan People's Hospital, Zhongshan, 528403, China.
  • Fu XY; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Lyu XM; Department of Otorhinolaryngology Head and Neck Surgery, General Hospital of Southern Theater Command, People's Liberation Army of China, Guangzhou, 510010, China.
  • Li MY; Department of laboratory medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510000, China.
  • Huang ZX; Department of Radiotherapy, Tumor Hospital of Zhongshan People's Hospital, Zhongshan, 528403, China. lmy.69@163.com.
  • Yao KT; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. zxhuang@smu.edu.cn.
Cancer Gene Ther ; 29(10): 1439-1451, 2022 10.
Article en En | MEDLINE | ID: mdl-35388172
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / Infecciones por Virus de Epstein-Barr Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Gene Ther Asunto de la revista: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / Infecciones por Virus de Epstein-Barr Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Gene Ther Asunto de la revista: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China